The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index; none of the 48 sources its claims cite is checked for support yet.
Hypoxia: an alarm signal during intestinal inflammation
Open accessAbstract
Intestinal epithelial cells that line the mucosal surface of the gastrointestinal tract are positioned between an anaerobic lumen and a highly metabolic lamina propria. As a result of this unique anatomy, intestinal epithelial cells function within a steep physiologic oxygen gradient relative to other cell types. Furthermore, during active inflammatory disease such as IBD, metabolic shifts towards hypoxia are severe. Studies in vitro and in vivo have shown that the activation of hypoxia-inducible factor (HIF) serves as an alarm signal to promote the resolution of inflammation in various mouse models of disease. Amelioration of disease occurs, at least in part, through transcriptional upregulation of nonclassic epithelial barrier genes. There is much interest in harnessing hypoxia-inducible pathways, including stabilizing HIF directly or via inhibition of prolyl hydroxylase enzymes, for therapy of IBD. In this Review, we discuss the signaling pathways involved in the regulation of hypoxia and discuss how hypoxia may serve as an endogenous alarm signal for the presence of mucosal inflammatory disease. We also discuss the pros and cons of targeting these pathways to treat patients with IBD.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This review argues that hypoxia in the inflamed intestinal mucosa acts as an endogenous alarm signal, with HIF activation promoting resolution of inflammation and barrier protection in murine colitis models. It discusses PHD inhibitors as potential IBD therapies but cautions about hematocrit elevation and cancer risk.
Key findings
- The intestinal mucosa normally exists in a steep oxygen gradient; 2-nitroimidazole dye studies in murine IBD models show physiologic hypoxia in normal colon and profoundly hypoxic or anoxic inflammatory lesions. The adult intestinal epithelium covers approximately 300 m² and absorbs at least 9 L of fluid daily; gut blood volume shifts from less than 5% during fasting to approximately 30% after a meal.
- HIF-1 is induced in inflammatory lesions. Loss of epithelial HIF-1α resulted in a more severe colitic phenotype than wild-type animals, with increased weight loss, decreased colon length and increased epithelial permeability, whereas constitutively active intestinal epithelial HIF was protective; however, another study found epithelial HIF-based signaling can promote inflammation.
- HIF-dependent barrier protection involves non-classical epithelial barrier genes, including mucins, intestinal trefoil factor, P-glycoprotein, CD73 and the adenosine A2B receptor, rather than tight junction proteins occludin or claudin. PHDs also regulate NF-κB via IKKβ hydroxylation.
- PHD inhibitors DMOG and FG-4497 reduced symptoms in at least two mouse models of colitis (TNBS or DSS) and were well tolerated; high-dose FG-4497 (>60 mg/kg) with 5 daily intervals caused occasional intestinal vascular occlusion, likely from erythrocyte sludging, rectified by lowering the dose and decreasing the dosing interval. No trials have been initiated for the treatment of IBD.
Methods
- Design: narrative review of hypoxia signaling in intestinal inflammation, synthesizing in vitro studies, murine disease models and patient-derived materials.
- Main analysis: descriptive synthesis of HIF, PHD and NF-κB pathways and preclinical therapeutic studies of PHD inhibitors in colitis models; no systematic search or quantitative meta-analysis is reported.
Limitations
- Stated: increased susceptibility to colitis after genetic deletion of intestinal epithelial HIF may be somewhat model-dependent and requires additional validation with PHD inhibitors before clinical studies can be implemented. The paper also cautions that HIF activators substantially elevate hematocrit; high-dose FG-4497 caused occasional vascular occlusion, and chronic HIF-1 and HIF-2 stabilization has been significantly associated with cancers, so safest use may be acute or short-term adjunct therapy.
- Evident from the text: this is a narrative review without systematic search or quantitative synthesis, and therapeutic evidence is largely from murine colitis models; no IBD trials have been initiated.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 48 cited sources checked · 0 supported · 0 flagged
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In our initial studies with murine colitis, we observed that high doses of FG-4497 (>60 mg/kg) with 5 daily intervals of dosing resulted in occasional vascular occlusion within the intestine.”
§ Hypoxia: an alarm signal during intestinal inflammation > Therapies for IBD
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Intestinal epithelial cells that line the mucosal surface of the gastrointestinal tract are positioned between an anaerobic lumen and a highly metabolic lamina propria. As a result of this unique anatomy, intestinal epithelial cells function within a steep physiologic oxygen gradient relative to other cell types.”
§ Hypoxia: an alarm signal during intestinal inflammation > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Rests on an assumption: There is a steep oxygen gradient from the anaerobic lumen of the intestine across the epithelium into the highly vascularized sub-epithelium.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Studies in vitro and in vivo have shown that the activation of hypoxia-inducible factor (HIF) serves as an alarm signal for the resolution of inflammation in various murine disease models.”
§ Hypoxia: an alarm signal during intestinal inflammation > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Amelioration of disease occurs, at least in part, through transcriptional up-regulation of non-classical epithelial barrier genes.”
§ Hypoxia: an alarm signal during intestinal inflammation > Abstract
What the sources say
- Not checked yetcites [4] Furuta, G. T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027–1034 (2001). source
- Not checked yetcites [20] Comerford, K. M. et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387–3394 (2002).
- Not checked yetcites [21] Synnestvedt, K. et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 (HIF-1) mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993–1002 (2002). source
- Not checked yetcites [22] Eltzschig, H. K. et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783–796 (2003). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“Furthermore, during active inflammatory disease such as IBD, metabolic shifts toward hypoxia are severe.”
- Also stated in: § Hypoxia and the immune response · plain
“IBD is an interesting disease for studying the metabolic changes associated with inflammation, particularly the development of hypoxia within inflammatory lesions3.”
§ Hypoxia: an alarm signal during intestinal inflammation > Abstract
What the sources say
- Not checked yetcites [3] Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295–1300 (2008). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes- Also stated in: § Hypoxia and the immune response · plain
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we review the signaling pathways involved and define how hypoxia may serve as an endogenous alarm signal for mucosal inflammatory disease.”
§ Hypoxia: an alarm signal during intestinal inflammation > Abstract
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“The same series of studies which identified inflammation-related hypoxia also showed that expression of HIF-1 is induced in the inflammatory lesions13.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [13] Karhausen, J. et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114, 1098–1106 (2004). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Several studies have shown that HIF-1 triggers the transcription of many genes that enable intestinal epithelial cells to act as an effective barrier4,20–22.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [4] Furuta, G. T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027–1034 (2001). source
- Not checked yetcites [20] Comerford, K. M. et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387–3394 (2002).
- Not checked yetcites [21] Synnestvedt, K. et al. Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 (HIF-1) mediates permeability changes in intestinal epithelia. J. Clin. Invest. 110, 993–1002 (2002). source
- Not checked yetcites [22] Eltzschig, H. K. et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J. Exp. Med. 198, 783–796 (2003). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“These findings may be somewhat model-dependent, since epithelial HIF-based signaling has also been shown to promote inflammation in another study27.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [27] Shah, Y. M. et al. Hypoxia-inducible factor augments experimental colitis through an MIF-dependent inflammatory signaling cascade. Gastroenterology 134, 2036–2048 (2008). source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“Finally, compelling evidence have revealed that HIF-1α transcriptionally controls the critical integrin important in all myeloid cell adhesion and transmigration, namely the β2 integrin (CD18)34,35.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [34] Kong, T., Eltzschig, H. K., Karhausen, J., Colgan, S. P. & Shelley, C. S. Leukocyte adhesion during hypoxia is mediated by HIF-1-dependent induction of beta2 integrin gene expression. Proc. Natl Acad. Sci. USA 101, 10440–10445 (2004). source
- Not checked yetcites [35] Kong, T., Scully, M., Shelley, C. S. & Colgan, S. P. Identification of Pur alpha as a new hypoxia response factor responsible for coordinated induction of the beta 2 integrin family. J. Immunol. 179, 1934–1941 (2007). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- Probably not a substantial claim. 5
- It may state two separate claims as one. 18
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In our experience, both FG-4497 and DMOG can be delivered by multiple routes of administration (intraperitoneal, oral and intravenous)., and both FG-4497 are absorbed orally with only a slight loss of efficacy compared to intraperitoneal administration.”
§ Hypoxia: an alarm signal during intestinal inflammation > Therapies for IBD
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“This problem was rectified by lowering the dose and decreasing the interval of dosing26.”
§ Hypoxia: an alarm signal during intestinal inflammation > Therapies for IBD
What the sources say
- Not checked yetcites [26] Robinson, A. et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145–155 (2008). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Sites of mucosal inflammation are characterized by profound changes in tissue metabolism, including local depletion of nutrients, imbalances in tissue oxygen supply and demand, and the generation of large quantities of reactive nitrogen and oxygen intermediates3.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia and the immune response
What the sources say
- Not checked yetcites [3] Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295–1300 (2008). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Notably, the PMN oxidative burst is not hindered by even relatively low O2 (as low as 4.5% O2)8, which is important, since it means that ROS can be generated in the relatively low O2 environments of inflamed intestinal mucosa3.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia and the immune response
What the sources say
- Not checked yetcites [8] Gabig, T. G., Bearman, S. I. & Babior, B. M. Effects of oxygen tension and pH on the respiratory burst of human neutrophils. Blood 53, 1133–1139 (1979). source
- Not checked yetcites [3] Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295–1300 (2008). source
Load-bearingStrength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Both the absorptive and barrier functions of the intestinal epithelium are regulated by the availability of O23.”
§ Hypoxia: an alarm signal during intestinal inflammation > Introduction
What the sources say
- Not checked yetcites [3] Taylor, C. T. & Colgan, S. P. Hypoxia and gastrointestinal disease. J. Mol. Med. 85, 1295–1300 (2008). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In fact, studies comparing functional responses between epithelial cells from different tissues have revealed that intestinal epithelial cells seem to be uniquely resistant to hypoxia and that an extremely low level of oxygenation within the normal intestinal epithelial barrier (so-called “physiologic hypoxia”) may be a regulatory adaptation mechanism to the steep oxygen gradient4.”
§ Hypoxia: an alarm signal during intestinal inflammation > Introduction
What the sources say
- Not checked yetcites [4] Furuta, G. T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027–1034 (2001). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ongoing studies suggest that hypoxia-regulated pathways are highly associated with IBD and contribute particularly to the resolution of ongoing inflammation.”
§ Hypoxia: an alarm signal during intestinal inflammation > Introduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes? Based: unclearIt may state two separate claims as one.
In the paper
“It has long been known that PMNs are primarily glycolytic cells, with few mitochondria and little energy produced from respiration6.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia and the immune response
What the sources say
- Not checked yetcites [6] Borregaard, N. & Herlin, T. Energy metabolism of human neutrophils during phagocytosis. J. Clin. Invest. 70, 550–557 (1982). source
Load-bearingStrength:boosted· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Loss of epithelial HIF-1α resulted in a more severe colitic phenotype than wild-type animals, with increased weight loss, decreased colon length and increased epithelial permeability, whereas constitutively active intestinal epithelial HIF was protective for these parameters.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [13] Karhausen, J. et al. Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J. Clin. Invest. 114, 1098–1106 (2004). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Second, the inflammatory lesions seen in these mouse models are profoundly hypoxic or even anoxic, similar to that seen in some large tumors, and penetrate deep into the mucosal tissue.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia and the immune response
What the sources say
- Not checked yetcites [14] Evans, S. M. et al. Detection of hypoxia in human squamous cell carcinoma by EF5 binding. Cancer Res. 60, 2018–2024 (2000).
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In particular, these studies have shown that PMN and macrophage bacterial killing capacities are severely limited in the absence of HIF-1α, as HIF-1α is central to production of antimicrobial peptides and granule proteases.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [33] Nizet, V. & Johnson, R. S. Interdependence of hypoxic and innate immune responses. Nat. Rev. Immunol. 9, 609–617 (2009). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Four HIF-hydroxylases termed PHD1-3 and Functional Inhibitor of HIF (FIH) have been demonstrated to be important in the hypoxic regulation of the HIF pathway37.”
§ Hypoxia: an alarm signal during intestinal inflammation > Prolyl-hydroxylases and HIF Expression
What the sources say
- Not checked yetcites [37] Kaelin, W. G. Jr & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393–402 (2008). source
Strength:boosted· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Likewise, NF-κB is thought to be largely protective in the intestinal epithelium via the inhibition of enterocyte apoptosis leading to enhanced intestinal barrier function23.”
§ Hypoxia: an alarm signal during intestinal inflammation > Prolyl-hydroxylases and HIF Expression
What the sources say
- Not checked yetcites [23] Cummins, E. P. et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134, 156–165 (2008). source
Strength:hedged· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Rather, the HIF-dependent pathways are more to do with overall tissue integrity, ranging from increased mucin production,31 including molecules that modify mucins, such as, intestinal trefoil factor4, to xenobiotic clearance by P-glycoprotein,20 to nucleotide metabolism (by ecto-5′-nucleotidase and CD73)21,22 and nucleotide signaling through the adenosine A2B receptor22.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
What the sources say
- Not checked yetcites [31] Louis, N. A. et al. Selective induction of mucin-3 by hypoxia in intestinal epithelia. J. Cell Biochem. 99, 1616–1627 (2006). source
- Not checked yetcites [4] Furuta, G. T. et al. Hypoxia-inducible factor 1-dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J. Exp. Med. 193, 1027–1034 (2001). source
- Not checked yetcites [20] Comerford, K. M. et al. Hypoxia-inducible factor-1-dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res. 62, 3387–3394 (2002).
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Indeed, hypoxia has been shown to activate NF-κB and this seems, at least in part to be, to be dependent on PHD-mediated hydroxylation38,49 of IKKβ.38”
§ Hypoxia: an alarm signal during intestinal inflammation > Convergence of inflammation and hypoxia
What the sources say
- Not checked yetcites [38] Cummins, E. P. et al. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. Proc. Natl Acad. Sci. USA 103, 18154–18159 (2006). source
- Not checked yetcites [49] Cockman, M. E. et al. Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH). Proc. Natl Acad. Sci. USA 103, 14767–14772 (2006). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the findings confirmed that intestinal epithelial cells can adapt to hypoxia and that HIF may contribute to this.”
§ Hypoxia: an alarm signal during intestinal inflammation > Hypoxia-inducible factor
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“For example, NF-κB has recently been reported to be regulated by HIF hydroxylases in a number of studies37,44.”
§ Hypoxia: an alarm signal during intestinal inflammation > Prolyl-hydroxylases and HIF Expression
What the sources say
- Not checked yetcites [37] Kaelin, W. G. Jr & Ratcliffe, P. J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 30, 393–402 (2008). source
- Not checked yetcites [44] Taylor, C. T. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J. Physiol. 586, 4055–4059 (2008). source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“In these mouse models, the drugs were well tolerated with no significant adverse side effects.”
§ Hypoxia: an alarm signal during intestinal inflammation > Therapies for IBD
What the sources say
- Not checked yetcites [23] Cummins, E. P. et al. The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology 134, 156–165 (2008). source
- Not checked yetcites [26] Robinson, A. et al. Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition. Gastroenterology 134, 145–155 (2008). source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is notable that the increased susceptibility to colitis following the genetic deletion of intestinal epithelial HIF may be somewhat model-dependent and will require additional validatation with PHD inhibitors before clinical studies can be implements.”
§ Hypoxia: an alarm signal during intestinal inflammation > Conclusions
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
In the paper
“It is notable that conditional deletion of the NF-κB pathway in intestinal epithelial cells in mice leads to an increased susceptibility to colitis50, similar to that of the mice expressing homozygous mutant HIF1α13.”
§ Hypoxia: an alarm signal during intestinal inflammation > Convergence of inflammation and hypoxia
What the sources say
- Not checked yetcites [50] Zaph, C. et al. Epithelial-cell-intrinsic IKK-beta expression regulates intestinal immune homeostasis. Nature 446, 552–556 (2007). source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This implicates epithelial NF-κB in a prominently protective role in colitis, probably through the expression of anti-apoptotic genes in intestinal epithelial cells and through enhanced epithelial barrier function.”
§ Hypoxia: an alarm signal during intestinal inflammation > Convergence of inflammation and hypoxia
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
The paper relies on this without support.
Loss of epithelial barrier function with unrestricted flux of luminal antigens to the mucosal immune system underlies the pathology of IBD and results in hypoxia within the chronically inflamed mucosa, particularly within the epithelial cell layer.
“Loss of epithelial barrier function with the resultant unrestricted flux of luminal antigens to the mucosal immune system underlies the pathology of IBD, and results in hypoxia within the chronically inflamed mucosa, particularly within the epithelial cell layer.”
The paper relies on this without support.
When activated, PMN can consume up to 10 times more O2 than any other cell in the body.
“When activated, it is estimated that PMN can consume up to 10 times more O2 than any other cell in the body.”
The paper relies on this without support.
There is a steep oxygen gradient from the anaerobic lumen of the intestine across the epithelium into the highly vascularized sub-epithelium.
“Notably, there is a steep oxygen gradient from the anaerobic lumen of the intestine across the epithelium into the highly vascularized sub-epithelium.”
The paper relies on this without support.
Chronic HIF-1 and HIF-2 stabilization are significantly associated with a number of cancers.
“As a second precautionary note, chronic HIF-1 and HIF-2 stabilization have been significantly associated with a number of cancers.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inflammation-associated hypoxia (or inflammatory hypoxia) can result from a combination of factors that result in a shift in metabolic supply and demand.”
From Hypoxia and hypoxia-inducible factors as regulators of T cell development, differentiation, and function (2013) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Prolyl hydroxylase is described as both stabilizing and degrading HIF
MinorThe abstract says the prolyl-hydroxylase enzyme stabilizes HIF, but the main text says these enzymes lead to HIF degradation and that inhibiting them stabilizes HIF.
“the proyl-hydroxylase enzyme (which stabilizes HIF)”
“these enzymes hydroxylate HIF alpha subunits leading to directed ubiquitination and subsequent degradation. Hypoxia or pharmacologic agents (such as DMOG) inhibit HIF-hydroxylases leading to derepression of HIF.”
Citations
Cites
Cellular Motility Driven by Assembly and Disassembly of Actin Filaments
Pollard, T. D., & Borisy, G. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00120-x · Cited by 4,334
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.
Kaelin, W. G., & Ratcliffe, P. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.04.009 · Cited by 3,251
Oxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
Chen, Z., Hagler, J., Palombella, V. J., Melandri, F. D., Scherer, D. C., Ballard, D. W., & Maniatis, T. (1995) · Genes & Development · doi:10.1101/gad.9.13.1586 · Cited by 1,270
Ubiquitin signalling in the NF-κB pathway
Chen, Z. J. (2005) · Nature Cell Biology · doi:10.1038/ncb0805-758 · Cited by 1,184
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
Luo, J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26322 · Cited by 898
Fuel feeds function: energy metabolism and the T-cell response
Fox, C. J., Hammerman, P. S., & Thompson, C. B. (2005) · Nature reviews. Immunology · doi:10.1038/nri1710 · Cited by 841
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 101–200 of 457
Curcumin as a therapeutic agent in the chemoprevention of inflammatory bowel disease
Sreedhar, R., Arumugam, S., Thandavarayan, R. A., Karuppagounder, V., & Watanabe, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.03.007 · Cited by 77
REST mediates resolution of HIF-dependent gene expression in prolonged hypoxia
Cavadas, M. A. S., Mesnieres, M., Crifò, B., Manresa, M. C., Selfridge, A. C., Scholz, C. C., Cummins, E. P., Cheong, A., & Taylor, C. T. (2015) · Scientific Reports · doi:10.1038/srep17851 · Cited by 80
Self-citationLuo, B., Xiang, D., Nieman, D. C., & Chen, P. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.11.013 · Cited by 74
Wei, T.-T., Lin, Y., Tang, S.-P., Luo, C.-K., Tsai, C.-C., Shun, C., & Chen, C. (2019) · Oncogene · doi:10.1038/s41388-019-0999-8 · Cited by 73
Interplay of Hypoxia and A2B Adenosine Receptors in Tissue Protection
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385526-8.00006-0 · Cited by 73
Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury
Kannan, K. B., Colorado, I., Reino, D. C., Palange, D., Lu, Q., Qin, X., Abungu, B., Watkins, A. C., Caputo, F. J., Xu, D.-Z., et al. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00459.2010 · Cited by 73
Hypoxia Modulates Infection of Epithelial Cells by Pseudomonas aeruginosa
Schaible, B., McClean, S., Selfridge, A. C., Broquet, A. H., Asehnoune, K., Taylor, C. T., & Schaffer, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056491 · Cited by 70
Self-citationBioengineered Systems and Designer Matrices That Recapitulate the Intestinal Stem Cell Niche
Wang, Y., Kim, R., Hinman, S. S., Zwarycz, B., Magness, S. T., & Allbritton, N. L. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.01.008 · Cited by 73
Ambrose, T., & Simmons, A. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy185 · Cited by 70
Tambuwala, M. M., Manresa, M. C., Cummins, E. P., Aversa, V., Coulter, I. S., & Taylor, C. T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.022 · Cited by 69
Self-citationTnfa Signaling Through Tnfr2 Protects Skin Against Oxidative Stress–Induced Inflammation
Candel, S., de Oliveira, S., López‐Muñoz, A., García‐Moreno, D., Espín-Palazón, R., Tyrkalska, S. D., Cayuela, M. L., Renshaw, S. A., Corbalán-Vélez, R., Vidal-Abarca, I., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001855 · Cited by 69
Curtis, V. F., Ehrentraut, S., Campbell, E. L., Glover, L. E., Bayless, A., Kelly, C. J., Kominsky, D. J., & Colgan, S. P. (2014) · The FASEB Journal · doi:10.1096/fj.14-259663 · Cited by 69
Self-citationTolstanova, G. M., Deng, X., French, S. W., Lungo, W., Paunovic, B., Khomenko, T., Ahluwalia, A., Kaplan, T. M., Dacosta-Iyer, M. G., Tarnawski, A. S., et al. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.122 · Cited by 68
Anatomical localization of commensal bacteria in immune cell homeostasis and disease
Fung, T. C., Artis, D., & Sonnenberg, G. F. (2014) · Immunological Reviews · doi:10.1111/imr.12186 · Cited by 75
Dulai, P. S., Buckey, J. C., Raffals, L. E., Swoger, J. M., Claus, P. L., O’Toole, K. S., Ptak, J. A., Gleeson, M. W., Widjaja, C. E., Chang, J. T., et al. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0005-z · Cited by 68
The emerging role for metabolism in fueling neutrophilic inflammation
Morrison, T., Watts, E., Sadiku, P., & Walmsley, S. R. (2022) · Immunological Reviews · doi:10.1111/imr.13157 · Cited by 67
Hypercapnia Suppresses the HIF-dependent Adaptive Response to Hypoxia
Selfridge, A. C., Cavadas, M. A. S., Scholz, C. C., Campbell, E. L., Welch, L. C., Lecuona, E., Colgan, S. P., Barrett, K. E., Sporn, P. H. S., Sznajder, J. I., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.713941 · Cited by 68
Self-citationGarhyan, J., Bhuyan, S., Pulu, I., Kalita, D., Das, B., & Bhatnagar, R. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.03.028 · Cited by 65
Microbial Metabolite Regulation of Epithelial Cell-Cell Interactions and Barrier Function
Ornelas, A., Dowdell, A. S., Lee, J. S., & Colgan, S. P. (2022) · Cells · doi:10.3390/cells11060944 · Cited by 69
Self-citationCuciniello, R., Meo, F. D., Filosa, S., Crispi, S., & Bergamo, P. (2023) · Antioxidants · doi:10.3390/antiox12051073 · Cited by 69
Oxygen in the regulation of intestinal epithelial transport
Ward, J. B. J., Keely, S., & Keely, S. J. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.270249 · Cited by 65
Muenchau, S., Deutsch, R., de Castro, I. J., Hielscher, T., Heber, N., Niesler, B., Lušić, M., Stanifer, M. L., & Boulant, S. (2019) · Molecular and Cellular Biology · doi:10.1128/mcb.00553-18 · Cited by 62
Yang, J., Bai, Y., Shen, S., Tao, X., Ma, C., Fu, B., Dai, Q., Wu, J., Meng, Z., Sun, Q., et al. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.142940 · Cited by 61
Long-term in vitro 3D hydrogel co-culture model of inflammatory bowel disease
Dosh, R. H., Jordan, N., Sammon, C., & Maitre, C. L. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-38524-8 · Cited by 63
Creating a More Perfect Union: Modeling Intestinal Bacteria-Epithelial Interactions Using Organoids
Han, X., Mslati, M., Davies, E., Chen, Y., Allaire, J. M., & Vallance, B. A. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.04.010 · Cited by 67
Hypoxia signaling during intestinal ischemia and inflammation
Grenz, A., Clambey, E. T., & Eltzschig, H. K. (2012) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e3283514bd0 · Cited by 60
Chen, P. X., Zhang, H., Marcone, M. F., Pauls, K. P., Liu, R., Tang, Y., Zhang, B., Renaud, J. B., & Tsao, R. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2016.12.027 · Cited by 59
Pan, X., Gong, D., Nguyen, D. N., Zhang, X., Hu, Q., Lu, H., Fredholm, M., Sangild, P. T., & Gao, F. (2018) · DNA Research · doi:10.1093/dnares/dsy001 · Cited by 59
Hypoxia signaling during acute lung injury
Vohwinkel, C. U., Hoegl, S., & Eltzschig, H. K. (2015) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00226.2015 · Cited by 58
The hypoxia-inducible factor (HIF) couples immunity with metabolism
Halligan, D. N., Murphy, S. J. E., & Taylor, C. T. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.004 · Cited by 59
Self-citationBäcker, V., Cheung, F.-Y., Siveke, J. T., Fandrey, J., & Winning, S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0190074 · Cited by 58
Yang, S., Fan, X., Ding, W., Liu, B., Meng, J., Xu, D., He, C., Yu, W., Wu, X., & Li, J. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2014.10.018 · Cited by 58
Rivera, K. R., Yokus, M. A., Erb, P. D., Pozdin, V. A., & Daniele, M. (2019) · The Analyst · doi:10.1039/c8an02201a · Cited by 57
Regulation of Oxygen Homeostasis at the Intestinal Epithelial Barrier Site
Konjar, Š., Pavšič, M., & Veldhoen, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179170 · Cited by 58
Flannigan, K. L., Agbor, T. A., Motta, J., Ferraz, J. G., Wang, R., Buret, A. G., & Wallace, J. L. (2014) · The FASEB Journal · doi:10.1096/fj.14-266015 · Cited by 57
Lei, L., Zhang, J., Decker, E. A., & Zhang, G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.665591 · Cited by 57
Effects of bovine lactoferrin on the immature porcine intestine
Nguyen, D. N., Li, Y., Sangild, P. T., Bering, S. B., & Chatterton, D. E. W. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002456 · Cited by 56
Vidaković, A., Huyben, D. C., Sundh, H., Nyman, A., Vielma, J., Passoth, V., Kiessling, A., & Lundh, T. (2019) · Aquaculture Nutrition · doi:10.1111/anu.12988 · Cited by 56
Hasan, F., Chiu, Y., Shaw, R., Wang, J., & Yee, C. (2021) · JCI Insight · doi:10.1172/jci.insight.138970 · Cited by 56
Causal effects of inflammatory protein biomarkers on inflammatory diseases
Ek, W. E., Karlsson, T., Höglund, J., Rask‐Andersen, M., & Johansson, Å. (2021) · Science Advances · doi:10.1126/sciadv.abl4359 · Cited by 55
Gas Exchange Disturbances Regulate Alveolar Fluid Clearance during Acute Lung Injury
Vadász, I., & Sznajder, J. I. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00757 · Cited by 58
Iron metabolism in colorectal cancer: a balancing act
Estêvão, D., da Cruz-Ribeiro, M., Cardoso, A. P., Costa, Â. M., Oliveira, M. J., Duarte, T. L., & Cruz, T. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00828-3 · Cited by 56
The hypoxia–inflammation link and potential drug targets
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32834873fd · Cited by 54
Pearce, S., Lonergan, S. M., Huff-Lonergan, E. J., Baumgard, L. H., & Gabler, N. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143099 · Cited by 56
New insights into sickle cell disease
Sun, K., & Xia, Y. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f55f9 · Cited by 54
Jin, Y., & Blikslager, A. T. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00113.2016 · Cited by 53
The regulation of transcriptional repression in hypoxia
Cavadas, M. A. S., Cheong, A., & Taylor, C. T. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.02.024 · Cited by 55
Self-citationBartolini, I., Risaliti, M., Ringressi, M. N., Melli, F., Nannini, G., Amedei, A., Muiesan, P., & Taddei, A. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i20.2498 · Cited by 54
Zhi, X., Tao, J., Li, Z., Jiang, B., Jin, F., Yang, L., Xu, H., & Xu, Z. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.022 · Cited by 52
The microbiome and immunodeficiencies: Lessons from rare diseases
Pellicciotta, M., Rigoni, R., Falcone, E. L., Holland, S. M., VILLA, A. M., & Cassani, B. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.01.008 · Cited by 53
Crosstalk Between Staphylococcus aureus and Innate Immunity: Focus on Immunometabolism
Horn, C. M., & Kielian, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.621750 · Cited by 53
Lu, Y., Wu, C.-C., Huang, Y.-C., Huang, C.-Y., Yang, C.-Y., Lee, T., Chen, C.-F., & Yu, L. C. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.11 · Cited by 51
The Inflammatory Tissue Microenvironment in IBD
Colgan, S. P., Curtis, V. F., & Campbell, E. L. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31828dcaaf · Cited by 52
Self-citationHypoxia Positively Regulates the Expression of pH-Sensing G-Protein–Coupled Receptor OGR1 (GPR68)
de Vallière, C., Cosín‐Roger, J., Simmen, S., Atrott, K., Melhem, H., Zeitz, J., Madanchi, M., Tcymbarevich, I., Fried, M., Kullak-Ublick, G. A., et al. (2016) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.06.003 · Cited by 51
The transcription factor HIF-1α mediates plasticity of NKp46+ innate lymphoid cells in the gut
Krzywińska, E., Sobecki, M., Nagarajan, S., Zacharjasz, J., Tambuwala, M. M., Pelletier, A., Cummins, E. P., Gotthardt, D., Fandrey, J., Kerdiles, Y. M., et al. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20210909 · Cited by 51
Self-citationEhrentraut, S., Kominsky, D. J., Glover, L. E., Campbell, E. L., Kelly, C. J., Bowers, B., Bayless, A. J., & Colgan, S. P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1202041 · Cited by 50
Self-citationThe Tumor Suppressor Gene, RASSF1A, Is Essential for Protection against Inflammation -Induced Injury
Gordon, M., El‐Kalla, M., Zhao, Y., Fiteih, Y., Law, J., Volodko, N. V., Anwar‐Mohamed, A., El‐Kadi, A. O. S., Liu, L., Odenbach, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075483 · Cited by 49
Metabolic regulation of intestinal epithelial barrier during inflammation
Colgan, S. P., Curtis, V. F., Lanis, J. M., & Glover, L. E. (2014) · Tissue Barriers · doi:10.4161/21688362.2014.970936 · Cited by 51
Self-citationVavricka, S. R., Rogler, G., Maetzler, S., Misselwitz, B., Safroneeva, E., Frei, P., Manser, C. N., Biedermann, L., Fried, M., Higgins, P., et al. (2013) · Journal of Crohn s and Colitis · doi:10.1016/j.crohns.2013.07.011 · Cited by 49
Adenosine signaling in normal and sickle erythrocytes and beyond
Zhang, Y., & Xia, Y. (2012) · Microbes and Infection · doi:10.1016/j.micinf.2012.05.005 · Cited by 51
Protective role of short-chain fatty acids on intestinal oxidative stress induced by TNF-α
Ferrer, M., Buey, B., Grasa, L., Mesonero, J. E., & Latorre, E. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.11.002 · Cited by 50
Neutrophils and inflammatory resolution in the mucosa
Colgan, S. P. (2015) · Seminars in Immunology · doi:10.1016/j.smim.2015.03.007 · Cited by 48
Self-citationRao, P., & Suvas, S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800422 · Cited by 48
Hirota, K. (2020) · Biomedicines · doi:10.3390/biomedicines8020032 · Cited by 52
Gao, H., Ren, F., Wen, P., Xie, L. X., Wang, R., Yang, Z. N., & Li, Y. X. (2020) · Journal of Dairy Science · doi:10.3168/jds.2020-19063 · Cited by 49
Bioengineered Co-culture of organoids to recapitulate host-microbe interactions
Kim, M. B., Hwangbo, S., Jang, S., & Jo, Y. K. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100345 · Cited by 49
Bakirtzi, K., Law, I. K. M., Xue, X., Iliopoulos, D., Shah, Y. M., & Pothoulakis, C. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501443 · Cited by 47
Barrila, J., Yang, J., Crabbé, A., Sarker, S. F., Liu, Y., Ott, C. M., Nelman-Gonzalez, M. A., Clemett, S. J., Nydam, S. D., Forsyth, R. J., et al. (2017) · npj Microgravity · doi:10.1038/s41526-017-0011-2 · Cited by 47
Adenosine and gastrointestinal inflammation
Colgan, S. P., Fennimore, B. P., & Ehrentraut, S. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0990-0 · Cited by 47
Self-citationHydroxylase-dependent regulation of the NF-κB pathway
Scholz, C. C., & Taylor, C. T. (2013) · Biological Chemistry · doi:10.1515/hsz-2012-0338 · Cited by 46
Self-citationHypoxia-adaptive pathways: A pharmacological target in fibrotic disease?
Strowitzki, M. J., Ritter, A. S., Kimmer, G., & Schneider, M. A. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104364 · Cited by 47
Qian, T., Hong, J., Wang, L., Wang, Z., Zhou, L., Li, Y., Liu, R., & Chu, Y. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.04.005 · Cited by 46
Lin, F., & Young, H. A. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.47a3002 · Cited by 46
Qian, W., Huang, L., Xu, Y., Lu, W., Wen, W., Guo, Z., Zhu, W., & Li, Y. (2022) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izac225 · Cited by 44
Hydroxylases as therapeutic targets in inflammatory bowel disease
Cummins, E. P., Doherty, G. A., & Taylor, C. T. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.9 · Cited by 44
Self-citationActivation of HIF-1α does not increase intestinal tumorigenesis
Xue, X., Ramakrishnan, S. K., & Shah, Y. M. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00112.2014 · Cited by 46
Neutrophils as Components of Mucosal Homeostasis
Hall, C. H. T., Campbell, E. L., & Colgan, S. P. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.07.001 · Cited by 44
Self-citationRivera, K. R., Pozdin, V. A., Young, A. T., Erb, P. D., Wisniewski, N. A., Magness, S. T., & Daniele, M. A.-A. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.07.035 · Cited by 44
Probiotics for Alleviating Alcoholic Liver Injury
Gu, Z., Liu, Y., Hu, S., You, Y., Li, W., & Wang, Y. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/9097276 · Cited by 45
Yin, J., Zhou, C., Yang, K., Ren, Y., Qiu, Y., Xu, P., Xiao, W., & Yang, H. (2020) · Cell Biology International · doi:10.1002/cbin.11336 · Cited by 44
Jones, M. A., Cho, S. H., Patterson, N. H., de Plas, R. V., Spraggins, J. M., Boothby, M. R., & Caprioli, R. M. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c00446 · Cited by 43
Adegunsoye, A., & Balachandran, J. S. (2015) · Mediators of Inflammation · doi:10.1155/2015/510105 · Cited by 45
Pathophysiological mechanisms of death resistance in colorectal carcinoma
Huang, C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11777 · Cited by 45
Epithelial Barrier Regulation by Hypoxia-Inducible Factor
Glover, L. E., & Colgan, S. P. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201608-610mg · Cited by 43
Self-citationBrown, E., Rowan, C. R., Strowitzki, M. J., Fagundes, R. R., Faber, K. N., Güntsch, A., Halligan, D. N., Kugler, J., Jones, F., Lee, C. T., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902103r · Cited by 43
Self-citationNew role for ceramide in hypoxia and insulin resistance
Xia, Q., Lu, F., Wu, F., Huang, Z., Dong, H., Xu, L., & Gong, J. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i18.2177 · Cited by 43
Loss of PHLPP protects against colitis by inhibiting intestinal epithelial cell apoptosis
Wen, Y., Li, X., Goretsky, T., Weiss, H. L., Barrett, T. A., & Gao, T. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.07.012 · Cited by 43
Seike, K., Kiledal, E. A., Fujiwara, H., Henig, I. J., da Silva, M. B., van den Brink, M. R. M., Hein, R., Hoostal, M. J., Liu, C., Oravecz-Wilson, K. I., et al. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.007 · Cited by 46
Dexmedetomidine protects intestinal ischemia-reperfusion injury via inhibiting p38 MAPK cascades
Liu, X.-M., Chen, Q., Hu, Q., Liu, Z., Wu, Q., Liang, S., Zhang, H., Zhang, Q., & Zhang, X. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104444 · Cited by 42
Toullec, A., Buard, V., Rannou, E., Tarlet, G., Guipaud, O., Robine, S., Iruela‐Arispe, M. L., François, A., & Milliat, F. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.08.001 · Cited by 40
Li, Y., Pan, X., Nguyen, D. N., Ren, S., Moodley, A., & Sangild, P. T. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03062 · Cited by 40
Harnessing the potential of probiotics in the treatment of alcoholic liver disorders
Mishra, G., Singh, P. N. D., Molla, M., Yimer, Y. S., Dinda, S. C., Chandra, P., Singh, B. K., Dagnew, S. B., Assefa, A. N., & Ewunetie, A. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1212742 · Cited by 39
Zhou, Y., Yang, S., Guo, J., Dong, H., Yin, K., Huang, W. T., & Yang, R. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b05278 · Cited by 39
Burge, K. Y., Gunasekaran, A., Makoni, M. M., Mir, A. M., Burkhart, H. M., & Chaaban, H. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11143987 · Cited by 40
Völlger, L., Akong, K., Cox, L., Goldmann, O., Wang, Y., Schäfer, S. T., Naim, H. Y., Nizet, V., & von Köckritz‐Blickwede, M. (2016) · Bioscience Reports · doi:10.1042/bsr20160031 · Cited by 39
The functional interplay between the HIF pathway and the ubiquitin system – more than a one-way road
Günter, J., Ruiz‐Serrano, A., Pickel, C., Wenger, R. H., & Scholz, C. C. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.027 · Cited by 40
The role of hypoxia-inducible factor 1α in hepatic lipid metabolism
Luo, M., Li, T., & Sang, H. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02308-5 · Cited by 42
Fofanova, T. Y., Stewart, C. J., Auchtung, J. M., Wilson, R. L., Britton, R. A., Grande-Allen, K. J., Estes, M., & Petrosino, J. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/555755 · Cited by 37
Metabolic regulation of oxygen and redox homeostasis by p53: Lessons from evolutionary biology?
Zhuang, J., Ma, W., Lago, C. U., & Hwang, P. M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.07.026 · Cited by 37
Bakirtzi, K., West, G. A., Fiocchi, C., Law, I. K. M., Iliopoulos, D., & Pothoulakis, C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.015 · Cited by 36
Metadata
- Authors
- Colgan, S. P., & Taylor, C. T.
- Affiliations
- University of Colorado Denver (US)
- University College Dublin (IE)
- Corresponding author
- Colgan, Sean P.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2010-04-06
- Volume
- 7
- Issue
- 5
- Pages
- 281-287
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- PMC
- PMC4077542
- OpenAlex
- W2018782206
- Cited by
- 461
- References
- 63
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 28 · 2023: 26 · 2022: 28 · 2021: 35 · 2020: 20 · 2019: 31 · 2018: 32 · 2017: 33 · 2016: 38 · 2015: 37 · 2014: 31 · 2013: 29 · 2012: 21
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Research Repository UCD (University College Dublin) (submittedVersion, cc-by-nc-nd)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- Crohn's and Colitis Foundation of America
- Crohn's and Colitis Foundation
- National Institutes of Health (DE016191, DK-50189, HL60569)
- National Heart, Lung, and Blood Institute (R01HL060569, HL-60569)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK050189, R37DK050189, R29DK050189, DK-50189)
- National Institute of Dental and Craniofacial Research (P50DE016191, DE 016191)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- hypoxia, intestinal inflammation, inflammatory bowel disease, hypoxia-inducible factor, HIF stabilization, prolyl hydroxylase inhibition, intestinal epithelial barrier, oxygen gradients, inflammation resolution, mucosal inflammation
- MeSH terms
- Animals, Hypoxia, Humans, Intestinal Mucosa, Inflammatory Bowel Diseases, Oxidative Stress, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
